Resultados de la búsqueda

Devesa A, Delgado V, Valkovic L, Lima JAC, Nagel E, Ibanez B, Raman B. Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases. Circ Res (2025) 136:1454-1475

Ghigo A, Ameri P, Asnani A, Bertero E, de Boer RA, Farmakis D, González A, Heymans S, Ibáñez B, López-Fernández T, Lyon AR, Pollesello P, Rakisheva A, Stellos K, Streckfuss-Bömeke K, Tocchetti CG, Thum T, van der Meer P, Van Rooij E, Ponikowski P, Metra M, Rosano G, Van Linthout S. Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart. Eur J Heart Fail (2025) 27:1028-1046
Link to the full text in Repisalud

Clemente-Moragón A, Suárez-Barrientos A, Gómez Tech M, López-Palomar Tech LP, Callejas Alejano S, Martínez F, Fernández FJ, Vega MC, Tech AP, Dopazo A, Sánchez-Cabo F, Fuster V, Oliver E, Ibáñez B. Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction. Nat Commun (2025) 16:10450
Link to the full text in Repisalud

Medina-Hernández D, Galán-Arriola C, Sánchez-González J, Ochala J, Ibáñez B. Anthracycline cardiotoxicity is associated with aberrant cardiac myosin energetics. Rev Esp Cardiol (2025) S1885-5857:00054-4

Rubini Giménez M, Koechlin L, López-Ayala P, Spagnuolo C, Boeddinghaus J, Wildi K, Nestelberger T, Tkachenko H, Basic D, Kaplan E, Formambuh J, Bima P, Glaeser J, Crisanti L, Miró Ó, Martín-Sánchez FJ, Christ M, Keller DI, Gualandro DM, Kawecki D, Rentsch K, Buser A, Strebel I, Mahfoud F, Mueller C; APACE Investigators; Hure G, Rumora K, Muench-Gerber T, Glarner N, Puelacher C, Twerenbold R, Wussler D, du Fay de Lavallaz J, Zimmermann T, Reinhardt J, Morawiec B, Munzk P, Geigy N, Shrestha S, Martinez-Nadal G, Fuenzalida C, Calderón S, Rodriguez Adrada E, Ganovská E, Parenica J, von Eckardstein A. Clinical implications of sex-specific upper reference limits for high-sensitivity cardiac troponin I in myocardial infarction diagnosis. Rev Esp Cardiol (2025) S1885-5857:00147-1

Sanz-Sánchez J, Santos Martínez S, Rumiz González E, Oteo Domínguez JF, Tejada Ponce D, Gómez Menchero A, Sánchez Elvira G, Fuertes Ferre G, Rivero Crespo F, Lukic Otanovic A, Díaz Fernández J, Galindo Fernández E, Urbano Carrillo C, Salvatella Giralt N, Torres Sánchez M, García Touchard A, Ibáñez Cabeza B, Stefanini G, Alfonso Manterola F, García García H, Amat-Santos IJ. Reduced stent strategy versus conventional percutaneous coronary revascularization in patients presenting with STEMI: the COPERNICAN trial. Rev Esp Cardiol (2025) S1885-5857:00150-1

Rossello X, Gonzalez-Manzanares R, Amat-Santos I, Peral Disdier V, Nieto Roca L, López Otero D, Nombela Franco L, Gheorge L, Sanz-Sánchez J, Gómez Herrero J, González Ferreiro R, Muñoz García AJ, Vilalta V, Ojeda S, Veiga Fernández G, Córdoba Soriano JG, Regueiro A, Sandín Rollán M, Flores Ríos X, Uribarri A, Martín Reyes R, Romaguera R, Avanzas P, García Blas S, Franco-Peláez JA, Martín Moreiras J, Ramón González Juanatey J, Tirado G, Calle G, Díez JL, Santos-Martínez S, Melendo Viu M, Carrillo Suarez X, Sanmartín X, Gonzalo N, Gutiérrez Barrios A, González Bermúdez I, Real C, Fuster V, Ibáñez B, Raposeiras-Roubín S. Use of the win ratio approach to assess outcomes in the DapaTAVI trial Rev Esp Cardiol (2025) S1885-5857:00241-5

Gómez-Talavera S, Navarro-Guzmán Á, Fernández-Jiménez R, Fuster V, Sánchez-González J, Ibáñez B. ESSOS single breath-hold 3D magnetic resonance for the assessment of aortic dilation. Rev Esp Cardiol (2025) S1885-5857:00192-6

Salinas P, Romaguera R, Gómez-Lara J, Brugaletta S, Gómez-Menchero A, Martín P, Romero M, García-Blas S, Jiménez M, Jiménez VA, Bordes P, Bayón J, Salvatella N, Alameda M, Hyun-Lee D, Trillo-Nouche R, López-Benito M, Frutos A, Moreu J, García Del Blanco B, Mohandes M, Bosa Ojeda F, Hernández Hernández F, Pinar-Bermúdez E, Jiménez-Quevedo P, Rosselló X, Pocock S, Sabaté M, Gómez-Hospital JA, Comin-Colet J, Gonzalo N, Fernández Ortiz A; SUGAR trial Investigators. Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial. Heart (2025) Jun 25 [Epub ahead of print]